<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141665659170000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904025%26RESULT%3d1%26SIGN%3dQRoRuzmOO1%252fmwS97uqwzD90R3MI%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904025&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904025&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904025&amp;v=MjM3MDZHNEg5ak1xNDlIWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN0FQVFhNWmI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#36" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#37" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#40" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#42" data-title="1.3 观察指标">1.3 观察指标</a></li>
                                                <li><a href="#44" data-title="1.4 统计学处理">1.4 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#47" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#48" data-title="2.1 治疗效果">2.1 治疗效果</a></li>
                                                <li><a href="#51" data-title="2.2 GDF-15、GMP-140及sCD40L水平">2.2 GDF-15、GMP-140及sCD40L水平</a></li>
                                                <li><a href="#55" data-title="2.3 心功能与血管内皮功能">2.3 心功能与血管内皮功能</a></li>
                                                <li><a href="#57" data-title="2.4 不良反应发生情况">2.4 不良反应发生情况</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#62" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#50" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组患者治疗效果比较&lt;/b&gt;"><b>表</b>1 <b>两组患者治疗效果比较</b></a></li>
                                                <li><a href="#53" data-title="表2 两组患者GDF-15、GMP-140及sCD40L水平比较（&lt;image id=&quot;85&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904025_08500.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s) ">表2 两组患者GDF-15、GMP-140及sCD40L水平比较（<image id="85" type="formula" href="images/XXGK201904025_08500.jpg" display="inline" placement="inline"><alt></alt></image>±s) </a></li>
                                                <li><a href="#59" data-title="表3 两组患者心功能与血管内皮功能比较（&lt;image id=&quot;86&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904025_08600.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s) ">表3 两组患者心功能与血管内皮功能比较（<image id="86" type="formula" href="images/XXGK201904025_08600.jpg" display="inline" placement="inline"><alt></alt></image>±s) </a></li>
                                                <li><a href="#61" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;两组患者不良反应发生情况比较&lt;/b&gt;"><b>表</b>4 <b>两组患者不良反应发生情况比较</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="张凌宇.急性心肌梗死不同时间段冠脉血栓成分病理分析的研究[J].现代中西医结合杂志, 2015, 24 (19) :2096-2097." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDJH201519015&amp;v=Mjg1MDJuQlpyRzRIOVROcG85RVlZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBUFM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        张凌宇.急性心肌梗死不同时间段冠脉血栓成分病理分析的研究[J].现代中西医结合杂志, 2015, 24 (19) :2096-2097.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="张兰芳, 齐晓勇, 贾新未, 等.不同剂量瑞舒伐他汀对急性心肌梗死经皮冠状动脉介入治疗患者心肌再灌注及心功能的影响[J].中国临床药理学杂志, 2015, 31 (13) :1223-1226." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201513001&amp;v=MjQ3ODJIU2RMRzRIOVROckk5RlpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBSWk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        张兰芳, 齐晓勇, 贾新未, 等.不同剂量瑞舒伐他汀对急性心肌梗死经皮冠状动脉介入治疗患者心肌再灌注及心功能的影响[J].中国临床药理学杂志, 2015, 31 (13) :1223-1226.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="冯惠平, 冯惠清, 王占启, 等.瑞舒伐他汀对急性心肌梗死患者血清IL-6、GMP-140、BNP水平及心功能的影响[J].山东医药, 2014, 54 (11) :38-39." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYY201411016&amp;v=MTU1NjY0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBTmluU2Q3RzRIOVhOcm85RVlvUUtESDg0dlI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        冯惠平, 冯惠清, 王占启, 等.瑞舒伐他汀对急性心肌梗死患者血清IL-6、GMP-140、BNP水平及心功能的影响[J].山东医药, 2014, 54 (11) :38-39.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="Fraker TD, Fihn SD.2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina[J].J Am Coll Cardiol, 2007, 50 (23) :2264-2274." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develo">
                                        <b>[4]</b>
                                        Fraker TD, Fihn SD.2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina[J].J Am Coll Cardiol, 2007, 50 (23) :2264-2274.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="中华医学会心血管病学分会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2001, 16 (12) :710-725." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX200112002&amp;v=MjAyODl0RE5yWTlGWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN0FQeVhUZHJHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        中华医学会心血管病学分会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2001, 16 (12) :710-725.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Cung T T, Morel O, Cayla G, et al.Cyclosporine before PCI in patients with acute myocardial infarction[J].N Engl J Med, 2015, 373 (11) :1021-1031." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Cyclosporine before PCI in patients with acute myocardial infarction">
                                        <b>[6]</b>
                                        Cung T T, Morel O, Cayla G, et al.Cyclosporine before PCI in patients with acute myocardial infarction[J].N Engl J Med, 2015, 373 (11) :1021-1031.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="陈玉善, 解金红, 罗明华, 等.不同剂量瑞舒伐他汀对急性心肌梗死患者冠脉介入术后内皮功能的影响[J].中国心血管病研究, 2014, 12 (6) :539-542." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGZ201406027&amp;v=MTU3NDg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3QVBUWE1kTEc0SDlYTXFZOUhZNFFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        陈玉善, 解金红, 罗明华, 等.不同剂量瑞舒伐他汀对急性心肌梗死患者冠脉介入术后内皮功能的影响[J].中国心血管病研究, 2014, 12 (6) :539-542.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="余秉东, 杨笛.阿替普酶与尿激酶在急性心肌梗死患者中应用及效果[J].中国医药导报, 2014, 11 (1) :73-75." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YYCY201401024&amp;v=MzA0ODc0SDlYTXJvOUhZSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3QVBEVElkN0c=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        余秉东, 杨笛.阿替普酶与尿激酶在急性心肌梗死患者中应用及效果[J].中国医药导报, 2014, 11 (1) :73-75.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="戚德清, 许康世.GPⅡb基因型急性心肌梗死患者介入治疗前后GMP-140、vWF和PAI-1水平[J].贵阳医学院学报, 2014, 39 (1) :57-60." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GYYB201401019&amp;v=MDc2MDZxZlp1Wm1GeWpuVkw3QUlqVFNiTEc0SDlYTXJvOUViWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        戚德清, 许康世.GPⅡb基因型急性心肌梗死患者介入治疗前后GMP-140、vWF和PAI-1水平[J].贵阳医学院学报, 2014, 39 (1) :57-60.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="吴小燕, 吉贞料, 陈小紫.大剂量瑞舒伐他汀对急性心肌梗死患者的心功能和MMP-9及hsCRP的影响[J].河北医药, 2015, 37 (23) :3547-3549." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HBYZ201523008&amp;v=MjAwOTlBTFMvU2RMRzRIOVRPckk5RmJJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        吴小燕, 吉贞料, 陈小紫.大剂量瑞舒伐他汀对急性心肌梗死患者的心功能和MMP-9及hsCRP的影响[J].河北医药, 2015, 37 (23) :3547-3549.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="杨溶海, 方长庚, 梁建光.丹参多酚酸盐对急性心肌梗死患者血清sCD40L、E-选择素、P-选择素的影响[J].中国动脉硬化杂志, 2014, 22 (5) :502-504." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=KDYZ201405017&amp;v=MTI4MTh0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBTGluU2RMRzRIOVhNcW85RVk0UUtESDg0dlI0VDZqNTRPM3pxcUI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        杨溶海, 方长庚, 梁建光.丹参多酚酸盐对急性心肌梗死患者血清sCD40L、E-选择素、P-选择素的影响[J].中国动脉硬化杂志, 2014, 22 (5) :502-504.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="蒋桦, 夏春香, 李淑忱, 等.辛伐他汀对急性心肌梗死患者炎症水平和内皮功能的影响[J].血栓与止血学, 2014, 20 (2) :65-67." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XSZX201402005&amp;v=MTQ3NjhIOVhNclk5RllZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBUFQ3UmRyRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        蒋桦, 夏春香, 李淑忱, 等.辛伐他汀对急性心肌梗死患者炎症水平和内皮功能的影响[J].血栓与止血学, 2014, 20 (2) :65-67.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="张玉英, 陶志刚.大剂量瑞舒伐他汀治疗急性心肌梗死患者血清GDF-15、hsCRP水平变化及临床意义[J].山东医药, 2017, 57 (17) :75-77." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYY201717026&amp;v=MDM5NDJDVVI3cWZadVptRnlqblZMN0FOaW5TZDdHNEg5Yk5xSTlIWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        张玉英, 陶志刚.大剂量瑞舒伐他汀治疗急性心肌梗死患者血清GDF-15、hsCRP水平变化及临床意义[J].山东医药, 2017, 57 (17) :75-77.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="邓诗武.GDF-15、cTnI、BNP在急性心肌梗死病人中的关系及对其近期预后的预测价值[J].中西医结合心脑血管病杂志, 2017, 15 (18) :2294-2296." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201718022&amp;v=MzIzMjFyQ1VSN3FmWnVabUZ5am5WTDdBUHpUU2Q3RzRIOWJOcDQ5SFpvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0Y=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        邓诗武.GDF-15、cTnI、BNP在急性心肌梗死病人中的关系及对其近期预后的预测价值[J].中西医结合心脑血管病杂志, 2017, 15 (18) :2294-2296.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="张锦丽, 闫敏, 王璐琰.不同剂量阿替普酶溶栓治疗急性脑梗死效果评价[J].解放军医药杂志, 2014, 26 (11) :79-81, 88." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HBGF201411022&amp;v=MDAxNzVuVkw3QUxTL01hTEc0SDlYTnJvOUhab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        张锦丽, 闫敏, 王璐琰.不同剂量阿替普酶溶栓治疗急性脑梗死效果评价[J].解放军医药杂志, 2014, 26 (11) :79-81, 88.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),490-494 DOI:10.3969/j.issn.1008-0074.2019.04.25            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>阿替普酶联合瑞舒伐他汀治疗急性心肌梗死的疗效及对血</b>GDF-15、GMP-140、sCD40L<b>水平的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E7%8E%8B%E8%BE%89&amp;code=40731587&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">王辉</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E9%83%93%E5%9F%8E%E5%8E%BF%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=0068630&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">郓城县人民医院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探究阿替普酶联合瑞舒伐他汀治疗急性心肌梗死 (AMI) 患者的疗效及对血清生长分化因子 (GDF) -15、血浆血小板颗粒膜蛋白 (GMP) -140、可溶性T细胞CD40配体 (sCD40L) 水平的影响。<b>方法</b>:2015～2017年我市急救站接诊的AMI患者138例被随机分为瑞舒伐他汀组 (n=68) 与联合治疗组 (n=70, 在瑞舒伐他汀组基础上接受阿替普酶治疗) , 均治疗3周。对比两组患者临床疗效, 血清GDF-15、血浆GMP-140、sCD40L水平, 心功能。<b>结果</b>:联合治疗组治疗总有效率显著高于瑞舒伐他汀组 (95.71%比76.47%, <i>P</i>=0.001) ;与治疗前相比, 治疗后两组的血清GDF-15、血浆GMP-140及sCD40L水平均显著下降, 而左室射血分数 (LVEF) 及肱动脉内皮依赖性舒张功能 (FMD) 则显著上升 (<i>P</i>&lt;0.05或&lt;0.01) 。治疗后, 与瑞舒伐他汀组比较, 联合治疗组的血清GDF-15[ (874.24±146.65) ng/L比 (761.37±95.86) ng/L]、血浆GMP-140 [ (31.86±6.17) ng/ml比 (22.73±5.12) ng/ml]及sCD40L[ (52.38±9.55) mg/L比 (48.27±10.02) mg/L]水平下降更显著, 而LVEF[ (50.43±4.78) %比 (55.28±5.02) %]及FMD[ (7.26±1.07) %比 (8.84±1.23) %]则升高更显著, <i>P</i>&lt;0.05或&lt;0.01。两组不良反应率无显著差异 (<i>P</i>=0.561) 。<b>结论</b>:阿替普酶联合瑞舒伐他汀治疗急性心肌梗死患者可显著提高疗效, 降低血清GDF-15、血浆GMP-140及sCD40L水平, 并可提高心功能与内皮功能, 值得推广。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E8%82%8C%E6%A2%97%E6%AD%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心肌梗死;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%BB%84%E7%BB%87%E5%9E%8B%E7%BA%A4%E6%BA%B6%E9%85%B6%E5%8E%9F%E6%BF%80%E6%B4%BB%E7%89%A9&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">组织型纤溶酶原激活物;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%91%9E%E8%88%92%E4%BC%90%E4%BB%96%E6%B1%80&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">瑞舒伐他汀;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-01-31</p>

            </div>
                    <h1>Therapeutic effect of alteplase combined rosuvastatin on acute myocardial infarction and its influence on levels of serum GDF-15, plasma GMP-140 and sCD40L</h1>
                    <h2>
                    <span>WANG Hui</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, People′s Hospital of Yuncheng County</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To explore therapeutic effect of alteplase combined rosuvastatin on patients with acute myocardial infarction (AMI) and its influence on levels of serum growth differentiation factor (GDF) -15, plasma thrombolytic granule membrane protein (GMP) -140 and soluble T cell CD40 ligand (sCD40 L) . <b>Methods</b>:A total of 138 AMI patients treated in emergency station of our city from 2015 to 2017 were randomly divided into rosuvastatin group (n=68) and combined treatment group (n=70, received alteplase based on rosuvastatin group) , both groups were treated for three weeks. Therapeutic effects were compared between two groups. <b>Results</b>:Total effective rate of combined treatment group was significantly higher than that of rosuvastatin group (95.71% vs. 76.47%, <i>P</i>=0.001) . Compared with before treatment, there were significant reductions in levels of serum GDF-15, plasma GMP-140 and sCD40 L, and significant rise in LVEF and fore brachial artery endothelium dependent diastolic-systolic function (FMD) in two groups after treatment, <i>P</i>&lt;0.05 or &lt;0.01. Compared with rosuvastatin group after treatment, there were significant reductions in levels of serum GDF-15[ (874.24±146.65) ng/L vs. (761.37±95.86) ng/L], plasma GMP-140 [ (31.86±6.17) ng/ml vs. (22.73±5.12) ng/ml] and sCD40 L[ (52.38±9.55) mg/L vs. (48.27±10.02) mg/L], and significant rise in LVEF[ (50.43±4.78) % vs. (55.28±5.02) %] and FMD[ (7.26±1.07) % vs. (8.84±1.23) %] in combined treatment group, <i>P</i>&lt;0.05 or &lt;0.01. There was no significant difference in incidence rate of adverse reactions between two groups, <i>P</i>=0.561. <b>Conclusion</b>:Alteplase combined rosuvastatin can significantly improve therapeutic effect, reduce levels of serum GDF-15, plasma GMP-140 and sCD40 L, and improve cardiac function and endothelial function in AMI patients, which is worth extending.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Myocardial%20infarction&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Myocardial infarction;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Tissue%20plasminogen%20activator&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Tissue plasminogen activator;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Rosuvastatin&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Rosuvastatin;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-01-31</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="35">急性心肌梗死是由于冠状动脉缺血缺氧所致的心肌坏死, 冠状动脉硬化狭窄是导致该病的主要病理基础之一。急性心肌梗死为临床常见的心血管急危重症之一, 相关数据显示<citation id="69" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>, 该病发病率呈逐年上升趋势。急性心肌梗死发生后, 若治疗不及时可导致心律失常、休克或心力衰竭, 对患者生命安全产生严重威胁。瑞舒伐他汀为新型他汀类药物, 该药物具有降脂、抑制炎症反应、稳定粥样板块、抑制血栓形成等作用<citation id="70" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。冯惠平<citation id="71" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>研究中急性心肌梗死患者采用瑞舒伐他汀治疗, 使患者临床疗效显著提升, 炎症因子水平显著下降, 心功能得到显著改善。阿替普酶为血栓溶解药, 主要成分为糖蛋白, 静脉注射该药物可使阻塞的冠状动脉再通, 从而部分或完全恢复组织与器官血流灌注, 操作简单且见效快。但临床中有关阿替普酶与瑞舒伐他汀联合治疗急性心肌梗死患者的研究较少。本研究中急性心肌梗死患者采用注射用阿替普酶联合瑞舒伐他汀治疗, 取得满意效果, 现报道如下。</p>
                </div>
                <h3 id="36" name="36" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="37" name="37">1.1 一般资料</h4>
                <div class="p1">
                    <p id="38">选择2015年3月～2017年7月我市急救站接诊收治的138例急性心肌梗死患者作为研究对象, 采用随机字母表法分为联合治疗组 (70例) 和瑞舒伐他汀组 (68例) 。联合治疗组男47例, 女23例, 年龄46～71 (62.87±6.15) 岁;心梗部位:前壁心梗38例, 后壁心梗6例, 下壁心梗17例, 下壁+右室心梗8例。瑞舒伐他汀组男43例, 女25例, 年龄45～73 (63.38±5.82) 岁;心梗部位:前壁心梗34例, 后壁心梗10例, 下壁心梗13例, 下壁+右室心梗12例。两组患者一般资料相比差异无统计学意义 (<i>P</i>&gt;0.05) 。</p>
                </div>
                <div class="p1">
                    <p id="39">纳入标准:①符合急性心肌梗死诊断标准<citation id="72" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>, 并经临床及影像学诊断确诊;②心电图显示, 呈进行性心肌缺血改变;③均无药物相关禁忌症;④患者或其家属知晓本研究详情并签署同意书。排除标准:①合并活动性肝炎;②合并严重肝肾功能不全;③合并急慢性炎症;④合并血液系统疾病或免疫系统疾病;⑤合并感染性疾病或甲状腺功能异常;⑥入选前3个月内服用过他汀类药物;⑦有心肌梗死史;⑧预计生存期&lt;1年。</p>
                </div>
                <h4 class="anchor-tag" id="40" name="40">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="41">两组患者均给予一般治疗, 如给予β受体阻滞剂、硝酸酯类、血管紧张素转换酶抑制剂等, 均不给予氯吡格雷、阿司匹林等抗血栓药物。瑞舒伐他汀组患者瑞舒伐他汀 (生产厂家:鲁南贝特制药有限公司;批准文号:20130122;规格:原料药) , 口服, 10mg/次, 1次/d。联合治疗组患者在瑞舒伐他汀口服治疗基础上, 同时给予注射用阿替普酶 (生产厂家:德国博瑞有限公司生产;批准文号:S20110051;规格:20mg/支) , 0.9mg/kg (最大剂量≤50mg) , 静脉注射, 10min注射10%, 1h滴完, 每疗程仅第1d使用。两组患者均以3周为治疗周期。</p>
                </div>
                <h4 class="anchor-tag" id="42" name="42">1.3 观察指标</h4>
                <div class="p1">
                    <p id="43">①临床疗效:参照《急性心肌梗死诊断和治疗指南》<citation id="73" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>评定, 治疗后2h胸痛逐渐减轻至消失, 心功能提升2个等级, 无心律失常, 低血压休克得到纠正, 则评定为显效;治疗后胸痛发作次数减少, 疼痛程度显著减轻且持续时间缩短, ST段回到等电位线或下降不低于50%, 心功能提升1级, 则评定为有效;临床症状未显著改善或加重, 则评定为无效;②血生长分化因子 (growth differentiation factor, GDF-15) :分别于治疗前与治疗后3个月清晨取患者静脉血2ml, 以2500r/min离心20min, 分离血清, 置于-60℃冰箱内保存以备检测, 使用酶联免疫法测定;血浆α-颗粒膜蛋白-140 (Alpha-granule membrane protein-140, GMP-140) :分别于治疗前与治疗后3个月清晨取患者静脉血2ml, 20%EDTANa<sub>2</sub>抗凝, 离心后分离血浆, 置于-20℃冰箱内保存以备检测, 采用放射免疫法测定;可溶性白细胞分化抗原40配体 (soluble cluster of di-fferentiation antigen 40 ligand, sCD40L) 水平, 分别于治疗前与治疗后3个月清晨取患者静脉血2ml, 放入抗凝管, 注入1%二乙胺四乙酸钠0.5ml, 分离血清, 置于-20℃冰箱内保存以备检测, 采用双抗体夹心ABC-ELISA法检测;试剂盒由北京四正柏生物科技有限公司提供, 操作均按照试剂盒说明进行;③心功能与血管内皮功能:采用超声探头检测左心室射血分数 (LVEF) 及血管内皮舒张功能 (FMD) ;④记录两组患者不良反应发生情况。</p>
                </div>
                <h4 class="anchor-tag" id="44" name="44">1.4 统计学处理</h4>
                <div class="p1">
                    <p id="45">采用SPSS 21.0统计学软件处理。计量资料以均数±标准差 (<image id="84" type="formula" href="images/XXGK201904025_08400.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="47" name="47" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="48" name="48">2.1 治疗效果</h4>
                <div class="p1">
                    <p id="49">联合治疗组患者治疗有效率为95.71%, 显著高于瑞舒伐他汀组的76.47% (<i>P</i>=0.001) , 见表1。</p>
                </div>
                <div class="area_img" id="50">
                    <p class="img_tit"><b>表</b>1 <b>两组患者治疗效果比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="50" border="1"><tr><td><br />组别</td><td>显效<br /><i>n</i> (%) </td><td>有效<br /><i>n</i> (%) </td><td>无效<br /><i>n</i> (%) </td><td>总有效率<br /><i>n</i> (%) </td></tr><tr><td><br />联合治疗组 (n=70) </td><td>47 (67.14) </td><td>20 (28.57) </td><td>3 (4.29) </td><td>67 (95.71) <sup>△△</sup></td></tr><tr><td><br />瑞舒伐他汀组 (n=68) </td><td>29 (42.65) </td><td>23 (33.82) </td><td>16 (23.53) </td><td>52 (76.47) </td></tr><tr><td><br /><i>χ</i><sup>2</sup></td><td></td><td></td><td></td><td>10.759</td></tr><tr><td><br /><i>P</i></td><td></td><td></td><td></td><td>0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与瑞舒伐他汀组比较△△P&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="51" name="51">2.2 GDF-15、GMP-140及sCD40L水平</h4>
                <div class="p1">
                    <p id="52">两组患者治疗前GDF-15、GMP-140及sCD40L水平相比差异无统计学意义 (<i>P</i>&gt;0.05) , 两组患者治疗后GDF-15、GMP-140及sCD40L水平均较治疗前显著下降 (<i>P</i>均=0.001) , 联合治疗组低于瑞舒伐他汀组, 差异有统计学意义 (<i>P</i>&lt;0.05) , 见表2。</p>
                </div>
                <div class="area_img" id="53">
                    <p class="img_tit">表2 两组患者GDF-15、GMP-140及sCD40L水平比较（<image id="85" type="formula" href="images/XXGK201904025_08500.jpg" display="inline" placement="inline"><alt></alt></image>±s)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="53" border="1"><tr><td rowspan="2"><br />组别</td><td colspan="4"><br />GDF-15 (ng/L) </td><td colspan="4">GMP-140 (ng/ml) </td><td colspan="4">sCD40L (mg/L) </td></tr><tr><td>治疗前</td><td>治疗后</td><td><i>t</i></td><td><i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i></td><td><i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i></td><td><i>P</i></td></tr><tr><td>联合治疗组 (70例) </td><td>1258.72±<br />216.37</td><td>761.37±<br />95.86<sup>**△△</sup></td><td>17.583</td><td>0.001</td><td>50.16±<br />7.03</td><td>22.73±<br />5.12<sup>**△△</sup></td><td>26.388</td><td>0.001</td><td>56.73±<br />12.68</td><td>48.27±<br />10.02<sup>**△△</sup></td><td>4.380</td><td>0.001</td></tr><tr><td><br />瑞舒伐他汀组 (68例) </td><td>1266.85±<br />208.64</td><td>874.24±<br />146.65<sup>**</sup></td><td>12.695</td><td>0.001</td><td>49.96±<br />6.58</td><td>31.86±<br />6.17<sup>**</sup></td><td>16.547</td><td>0.001</td><td>57.46±<br />13.14</td><td>52.38±<br />9.55<sup>**</sup></td><td>2.579</td><td>0.011</td></tr><tr><td><br /><i>t</i></td><td>0.225</td><td>5.367</td><td></td><td></td><td>0.172</td><td>9.471</td><td></td><td></td><td>0.332</td><td>2.465</td><td></td><td></td></tr><tr><td><br /><i>P</i></td><td>0.823</td><td>0.001</td><td></td><td></td><td>0.863</td><td>0.001</td><td></td><td></td><td>0.740</td><td>0.015</td><td></td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:GDF-15:血生长分化因子15, GMP-140:血浆α-颗粒膜蛋白-140, sCD40L:可溶性白细胞分化抗原40配体。与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与瑞舒伐他汀组比较△<i>P</i>&lt;0.05。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="55" name="55">2.3 心功能与血管内皮功能</h4>
                <div class="p1">
                    <p id="56">两组患者治疗前LVEF及FMD相比差异无统计学意义 (<i>P</i>&gt;0.05) , 两组患者治疗后LVEF及FMD均较治疗前显著上升, 联合治疗组高于瑞舒伐他汀组, 差异有统计学意义 (<i>P</i>&lt;0.05) , 见表3。</p>
                </div>
                <h4 class="anchor-tag" id="57" name="57">2.4 不良反应发生情况</h4>
                <div class="p1">
                    <p id="58">联合治疗组患者不良反应发生率10.00%与瑞舒伐他汀组14.70%相比差异无统计学意义 (<i>P</i>&gt;0.05) , 见表4。</p>
                </div>
                <div class="area_img" id="59">
                                            <p class="img_tit">
                                                表3 两组患者心功能与血管内皮功能比较（<image id="86" type="formula" href="images/XXGK201904025_08600.jpg" display="inline" placement="inline"><alt></alt></image>±s) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904025_05900.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904025_05900.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904025_05900.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表3 两组患者心功能与血管内皮功能比较（&#177;s)" src="Detail/GetImg?filename=images/XXGK201904025_05900.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>

                </div>
                <div class="area_img" id="61">
                    <p class="img_tit"><b>表</b>4 <b>两组患者不良反应发生情况比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="61" border="1"><tr><td><br />组别</td><td>胃肠反应<br /><i>n</i> (%) </td><td>肌肉酸痛<br /><i>n</i> (%) </td><td>肌酸激酶升高<br /><i>n</i> (%) </td><td>胸闷<br /><i>n</i> (%) </td><td>总发生率<br /><i>n</i> (%) </td></tr><tr><td><br />联合治疗组 (70例) </td><td>3 (4.28) </td><td>1 (1.43) </td><td>2 (2.86) </td><td>1 (1.43) </td><td>7 (10.00) </td></tr><tr><td><br />瑞舒伐他汀组 (68例) </td><td>2 (2.94) </td><td>3 (4.41) </td><td>3 (4.41) </td><td>2 (2.94) </td><td>10 (14.70) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td></td><td></td><td></td><td>0.707/0.400</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="62" name="62" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="63">急性心肌梗死的病理学基础是冠状动脉粥样硬化破碎, 形成血栓, 从而堵塞冠状动脉, 为冠心病严重类型, 也是导致冠心病患者死亡或残疾的主要因素<citation id="74" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。因此, 及时对急性心肌梗死患者进行有效治疗对预后具有重要意义。他汀类药物是治疗与预防冠心病最有效的药物, 可有效抑制血栓形成, 降低血压, 改善血管内皮细胞功能等。瑞舒伐他汀为他汀类药物之一, 在人体中具有较强亲和力, 可有效预防心血管事件发生。相关研究指出<citation id="75" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>, 瑞舒伐他汀治疗急性心肌梗死比同类药物效果更显著。阿替普酶为血栓溶解药物, 主要为注射制剂, 该药物能够与纤维蛋白结合, 并促使与纤维蛋白结合的纤溶酶原转变为纤溶酶。同时, 阿替普酶具有选择性局部溶栓效果, 阿替普酶仅与血栓中的纤维蛋白结合, 不影响血液中纤维蛋白, 可有效避免非选择性溶栓所致全身纤溶状态。相关研究表明<citation id="76" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>, 阿替普酶联合瑞舒伐他汀治疗急性脑梗死相对单一用药效果更理想。</p>
                </div>
                <div class="p1">
                    <p id="64">GMP-140是血小板活化释放的特异性标志之一, 属嵌合蛋白, 位于α-颗粒膜上, 当血小板处于静止状态时, GMP-140含量较少, 血小板活化时, α-颗粒膜可与质膜迅速融合, 从而增加GMP-140表达水平, 可有效启动和扩大血栓形成<citation id="77" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。相关研究已证实<citation id="78" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>, 血小板活化可加重动脉阻塞或进一步狭窄。本研究显示, 两组患者治疗前GMP-140水平较高, 说明血小板显著活化, 可加重急性心肌梗死患者动脉阻塞程度。阿替普酶具有良好溶栓作用, 可抑制血小板活性。经注射用阿替普酶与瑞舒伐他汀治疗后, GMP-140水平显著降低。提示, 注射用阿替普酶联合瑞舒伐他汀可减少急性心肌梗死患者血小板活化, 阻止血栓形成。</p>
                </div>
                <div class="p1">
                    <p id="65">CD40-CD40L广泛存在于动脉粥样硬化的各种细胞, 为一对互补Ⅱ型跨膜糖蛋白。CD40-CD40L相互作用可促进人体内皮细胞、平滑肌细胞、细胞因子等表达水平, 从而影响动脉粥样硬化斑块稳定性, 促使动脉粥样硬化斑块由稳定向不稳定方向发展, 且二者相互作用可激活炎症介质, 促进炎症反应发生由此可见, 二者结合有可能介导各种炎性反应、基质降解、血栓形成等。临床研究已证实<citation id="79" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>, 心肌正常患者CD40水平低, 而患有心肌炎、心肌病等患者CD40水平高。蒋桦研究发现<citation id="80" type="reference"><link href="27" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>, 急性心肌梗死患者循环中sCD40L浓度较高, 表明急性心肌梗死患者本身可能分泌sCD40L。本研究发现, 急性心肌梗死在治疗前sCD40L处于高水平, 比心肌正常患者水平高, 说明, 急性心肌梗死患者可能自身具有分泌sCD40L的能力, 与上述讨论相一致。经治疗后, 联合治疗组患者sCD40L水平显著低于瑞舒伐他汀组。表明, 注射用阿替普酶联合瑞舒伐他汀有效降低sCD40L水平。主要原因在于, 阿替普酶有效抑制血栓形成, 瑞舒伐他汀可有效增强心肌细胞功能, 二者联用可有效增强血栓溶解效果, 提高冠状动脉再通率, 抑制炎性因子释放, 从而促使sCD40L水平逐步恢复正常。</p>
                </div>
                <div class="p1">
                    <p id="66">GDF-15为转化生长因子, 正常心肌细胞中表达较少, 具有保护细胞的作用。急性心肌梗死发生与炎症反应密切相关, 如巨噬细胞产生的白介素-1β、肿瘤坏死因子-α等, 这些因子可诱导GDF-15快速表达。因此, GDF-15可在一定程度上提示疾病进展<citation id="81" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。临床研究指出<citation id="82" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>, 血清GDF-15水平是影响非ST段与ST段抬高型心肌梗死预后的独立危险因素, 血清GDF-15水平越高, 死亡风险越大, 已成为预测急性心肌梗死预后新的生物标志物。本研究结果显示, 两组患者治疗前 GDF-15表达强烈, 两组患者治疗后 GDF-15水平均显著下降。表明, 注射用阿替普酶与瑞舒伐他汀联合治疗急性心肌梗死患者可有效降低GDF-15水平, 对改善预后具有重要意义。</p>
                </div>
                <div class="p1">
                    <p id="67">由表3可知, 联合治疗组治疗后LVEF及FMD高于瑞舒伐他汀组且组间差异有统计学意义。表明, 注射用阿替普酶与瑞舒伐他汀联合治疗急性心肌梗死患者可有效改善心功能及血管内皮功能。原因在于, 阿替普酶为人体天然纤维蛋白酶原激活剂, 半衰期短, 且能够选择性溶栓, 小力强, 速度快, 提高阻塞血管再通率, 从而有效降低心功能与血管内皮功能损伤<citation id="83" type="reference"><link href="33" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。由表4可知, 两组患者不良反应发生率相比无显著差异。表明, 注射用阿替普酶与瑞舒伐他汀联合治疗急性心肌梗死患者安全性较高。本研究也存在一定不足之处, 如样本量选择较少, 未对长期应用效果进行监测, 因此, 今后研究可进一步扩大样本量, 加以长期效果监测, 以提高研究结果准确性。</p>
                </div>
                <div class="p1">
                    <p id="68">综上所述, 注射用阿替普酶溶栓效果显著, 与瑞舒伐他汀联合治疗急性心肌梗死患者临床疗效确切, 且可减轻炎性反应, 降低GDF-15、GMP-140及sCD40L水平, 改善心功能与内皮功能, 具有一定的临床应用价值。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDJH201519015&amp;v=Mjg1NjZHNEg5VE5wbzlFWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN0FQU25CWnI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>张凌宇.急性心肌梗死不同时间段冠脉血栓成分病理分析的研究[J].现代中西医结合杂志, 2015, 24 (19) :2096-2097.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201513001&amp;v=MjIyMDJIU2RMRzRIOVROckk5RlpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBSWk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>张兰芳, 齐晓勇, 贾新未, 等.不同剂量瑞舒伐他汀对急性心肌梗死经皮冠状动脉介入治疗患者心肌再灌注及心功能的影响[J].中国临床药理学杂志, 2015, 31 (13) :1223-1226.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYY201411016&amp;v=MDA2MzE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3QU5pblNkN0c0SDlYTnJvOUVZb1FLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>冯惠平, 冯惠清, 王占启, 等.瑞舒伐他汀对急性心肌梗死患者血清IL-6、GMP-140、BNP水平及心功能的影响[J].山东医药, 2014, 54 (11) :38-39.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="http://scholar.cnki.net/result.aspx?q=2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develo">

                                <b>[4]</b>Fraker TD, Fihn SD.2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina[J].J Am Coll Cardiol, 2007, 50 (23) :2264-2274.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX200112002&amp;v=MDk2NTJGeWpuVkw3QVB5WFRkckc0SHRETnJZOUZab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>中华医学会心血管病学分会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2001, 16 (12) :710-725.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Cyclosporine before PCI in patients with acute myocardial infarction">

                                <b>[6]</b>Cung T T, Morel O, Cayla G, et al.Cyclosporine before PCI in patients with acute myocardial infarction[J].N Engl J Med, 2015, 373 (11) :1021-1031.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGZ201406027&amp;v=MTA5NjRSN3FmWnVabUZ5am5WTDdBUFRYTWRMRzRIOVhNcVk5SFk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>陈玉善, 解金红, 罗明华, 等.不同剂量瑞舒伐他汀对急性心肌梗死患者冠脉介入术后内皮功能的影响[J].中国心血管病研究, 2014, 12 (6) :539-542.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YYCY201401024&amp;v=MjY3MTdJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBUERUSWQ3RzRIOVhNcm85SFk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>余秉东, 杨笛.阿替普酶与尿激酶在急性心肌梗死患者中应用及效果[J].中国医药导报, 2014, 11 (1) :73-75.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GYYB201401019&amp;v=MTU1NDJUU2JMRzRIOVhNcm85RWJZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdBSWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>戚德清, 许康世.GPⅡb基因型急性心肌梗死患者介入治疗前后GMP-140、vWF和PAI-1水平[J].贵阳医学院学报, 2014, 39 (1) :57-60.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HBYZ201523008&amp;v=MzIxOTE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3QUxTL1NkTEc0SDlUT3JJOUZiSVFLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>吴小燕, 吉贞料, 陈小紫.大剂量瑞舒伐他汀对急性心肌梗死患者的心功能和MMP-9及hsCRP的影响[J].河北医药, 2015, 37 (23) :3547-3549.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=KDYZ201405017&amp;v=MDQ1MDc0SDlYTXFvOUVZNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3QUxpblNkTEc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>杨溶海, 方长庚, 梁建光.丹参多酚酸盐对急性心肌梗死患者血清sCD40L、E-选择素、P-选择素的影响[J].中国动脉硬化杂志, 2014, 22 (5) :502-504.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XSZX201402005&amp;v=MjM5NDk5WE1yWTlGWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN0FQVDdSZHJHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>蒋桦, 夏春香, 李淑忱, 等.辛伐他汀对急性心肌梗死患者炎症水平和内皮功能的影响[J].血栓与止血学, 2014, 20 (2) :65-67.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SDYY201717026&amp;v=MzIyMTJGeWpuVkw3QU5pblNkN0c0SDliTnFJOUhZb1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>张玉英, 陶志刚.大剂量瑞舒伐他汀治疗急性心肌梗死患者血清GDF-15、hsCRP水平变化及临床意义[J].山东医药, 2017, 57 (17) :75-77.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201718022&amp;v=MDAxNTdCdEdGckNVUjdxZlp1Wm1GeWpuVkw3QVB6VFNkN0c0SDliTnA0OUhab1FLREg4NHZSNFQ2ajU0TzN6cXE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>邓诗武.GDF-15、cTnI、BNP在急性心肌梗死病人中的关系及对其近期预后的预测价值[J].中西医结合心脑血管病杂志, 2017, 15 (18) :2294-2296.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HBGF201411022&amp;v=MTU3NjU3cWZadVptRnlqblZMN0FMUy9NYUxHNEg5WE5ybzlIWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>张锦丽, 闫敏, 王璐琰.不同剂量阿替普酶溶栓治疗急性脑梗死效果评价[J].解放军医药杂志, 2014, 26 (11) :79-81, 88.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904025" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904025&amp;v=MjM3MDZHNEg5ak1xNDlIWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN0FQVFhNWmI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
